U.S. researchers are developing a blood test that can help identify people with liver disease, a common setback for those with hepatitis B. The test, which works by detecting an antibody that is present in people with liver damage, could help encourage more frequent liver monitoring and enable doctors to evaluate the efficacy of different treatments.

Related Summaries